Destiny Pharma: Notice of R&D Update Meeting

Spexis announces positive renal impairment clinical trial results with balixafortide

CEVEC: ROKOTE Laboratories licenses CEVEC’s CAP® Ad Technology for vaccine manufacturing

Atriva Therapeutics announces Topline Results from the Proof of Concept (POC) / Phase 2a RESPIRE study (zapnometinib) in patients hospitalized with COVID-19

ABIVAX PRESENTS FIRST-HALF 2022 FINANCIAL RESULTS AND OPERATIONS UPDATE

Newron provides H1 2022 results and updates on R&D and business activities

Marinomed to attend several upcoming investor and industry conferences

HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput screening in drug discovery

InflaRx to Present at Upcoming Scientific and Investor Conferences

InflaRx Announces Vilobelimab Phase III Results in Critically Ill COVID-19 Patients Published in The Lancet Respiratory Medicine